Subsequent research demonstrated that transplanted dopaminergic precursors could mature into neurons expressing TH, along with other neuronal markers such as βIII-tubulin, NF200, MAP2, and GFAP; these findings highlighted the promising role of hBFP-ASCs in PD therapies [29,33]. This evidence concerns the gene GFAP and Parkinson disease.